DSIP may influence neurotransmitters and the HPA stress axis, potentially affecting cortisol levels, growth hormone release, and stress resilience
Others with particular GIPR variants benefit from extended low-dose therapy or periodic dose adjustments
These can include injection site irritation, headache, flushing or warmth, fatigue, mild gastrointestinal discomfort such as nausea, dizziness, or changes in appetite
If you would like to learn more about laboratory preparation procedures, you can review our guide on how research peptides are reconstituted for laboratory use
Persistent symptoms may indicate the need for dose adjustment, additional diagnostic evaluation to rule out other gastrointestinal conditions, or consideration of alternative treatment options
Slater's Aesthetics Clinic August & September Specials